Tag: Healthcare Policy

Pharma – Asia, S America, MENA, ROW Regulatory News – March 2025

Biopharma

ARGENTINA ANMAT in numbers: Advertising Monitoring and Inspection Program The Program for Monitoring and Oversight of Advertising and Promotion of Products Subject to Health Surveillance is...

Drug Approvals, Drug Safety, Global Health, Healthcare Policy, Medical Regulations, Pharma Compliance, Pharma Industry, Pharma Regulations, Pharma Updates, Regulatory News

Adopting a Life Cycle Approach to Software Medical Devices: Regulatory Guidelines by Singapore HSA

Biopharma

whose third revision was issued by the Singapore Health Sciences Authority. The guideline is designed to cover software of all Risk Classifications, covering regulatory obligations throughout the entire...

Cybersecurity, Health Tech, Healthcare Policy, Healthcare Technology, Medical Device Standards, Post Market Surveillance, Product Registration, Quality Management System (QMS), Regulatory Compliance, Singapore Healthcare, Software Regulations